Moderna

(Fixed-Term) Manufacturing Associate, Drug Substance - Shift Position

Oxford, England, United Kingdom

Not SpecifiedCompensation
Junior (1 to 2 years), Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotechnology, ManufacturingIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant scientific field, such as Biology, Chemistry, or a related discipline, and demonstrate at least 2 years of experience in a manufacturing environment, preferably within the pharmaceutical or biotechnology industry. Strong knowledge of current Good Manufacturing Practices (cGMP) and health and safety regulations is essential, along with the ability to operate and maintain production equipment and perform routine maintenance tasks.

Responsibilities

As a Manufacturing Associate, you will operate and monitor production equipment while adhering to cGMP, SOPs, and health and safety procedures, maintain a clean and compliant work environment, execute operations and maintain accurate manufacturing documentation, perform routine equipment maintenance, troubleshoot digital and equipment-related issues, keep training records and operational logs up to date, and collaborate closely with QA and other cross-functional teams to meet production KPIs. You will also practice safe work habits, proactively identify and report safety concerns, and participate in multiple projects and continuous improvement initiatives.

Skills

cGMP
SOPs
GMP
Pharmaceutical Manufacturing
Equipment Maintenance
Troubleshooting
Documentation
Safety Regulations
Digital Equipment

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Key Metrics

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI